The role of the microRNA let 7 in diabetic proliferative vascular disease [ 2014 - 2016 ]

Research Grant

Researchers: Prof Karin Jandeleit-Dahm (Principal investigator) ,  Dr Phillip Kantharidis

Brief description Cardiovascular complications remain the major cause of mortality in diabetes and our current treatment strategies are insufficient to reduce this burden. We have obtained extensive data to show that a novel molecule (the micro RNA, let 7b) has antiproliferative and vasculoprotective effects in diabetes. Thus, we propose that modulation of micro RNA let 7b specifically in vascular smooth muscle cells within the vascular wall represents a promising target to combat cardiovascular disease, in particular in diabetes.

Funding Amount $AUD 674,084.59

Funding Scheme Project Grants

Notes Standard Project Grant